QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)

Mesoblast (MESO) News Today

$2.05
+0.01 (+0.49%)
(As of 03/4/2024 ET)
SourceHeadline
finance.yahoo.com logoMesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcript
finance.yahoo.com - March 3 at 12:35 PM
finance.yahoo.com logoMesoblast Limited (NASDAQ:MESO) Q2 2024 Earnings Call Transcript
finance.yahoo.com - March 3 at 12:35 PM
seekingalpha.com logoMesoblast Limited (MESO) Q2 2024 Earnings Call Transcript
seekingalpha.com - March 2 at 10:43 AM
finance.yahoo.com logoMesoblast First Half 2024 Earnings: EPS Beats Expectations, Revenues Lag
finance.yahoo.com - February 29 at 4:16 PM
fool.com.au logoMesoblast share price tumbles on US$32.5m half-year loss
fool.com.au - February 28 at 10:38 PM
globenewswire.com logoMesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023
globenewswire.com - February 28 at 5:57 PM
globenewswire.com logoMesoblast Financial Results and Corporate Update Webcast
globenewswire.com - February 26 at 7:00 AM
msn.com logoMesoblast Limited - Depositary Receipt () (MESO) Price Target Increased by 16.88% to 2.31
msn.com - February 24 at 1:09 PM
msn.com logoMesoblast gets FDA orphan drug status for Revascor
msn.com - February 15 at 12:50 PM
fool.com.au logoGuess which ASX 300 healthcare stock is surging 13% on FDA news
fool.com.au - February 14 at 8:56 PM
finance.yahoo.com logoUnited States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
finance.yahoo.com - February 14 at 8:56 PM
globenewswire.com logoUnited States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
globenewswire.com - February 14 at 7:46 PM
marketbeat.com logoMesoblast (NASDAQ:MESO) Rating Increased to Sell at StockNews.com
marketbeat.com - February 13 at 1:45 AM
ca.finance.yahoo.com logoMESO Jul 2024 2.500 call
ca.finance.yahoo.com - February 11 at 3:14 PM
marketbeat.com logoMesoblast (NASDAQ:MESO) Stock Price Crosses Below Fifty Day Moving Average of $2.00
marketbeat.com - February 7 at 9:20 AM
finance.yahoo.com logoCrohn's Disease Treatment Drug Market is Expected to Showcase a Significant Growth During Study Period (2019–2032) | DelveInsight
finance.yahoo.com - February 7 at 3:02 AM
finance.yahoo.com logoAppendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023
finance.yahoo.com - January 30 at 11:55 PM
marketbeat.com logoMesoblast Limited (NASDAQ:MESO) Given Average Rating of "Hold" by Analysts
marketbeat.com - January 28 at 2:36 AM
afr.com logoASX rebounds as Whitehaven, Mesoblast power up
afr.com - January 19 at 7:02 PM
markets.businessinsider.com logoFDA Grants Rare Pediatric Disease Designation For Mesoblast' Revascor In Children With Heart Disease
markets.businessinsider.com - January 19 at 12:11 AM
msn.com logoTop 10 at 10: FDA wins on a Friday
msn.com - January 18 at 7:10 PM
fool.com.au logoWhy are Mesoblast shares rocketing 28% today?
fool.com.au - January 18 at 7:10 PM
marketwatch.com logoMesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment
marketwatch.com - January 18 at 7:10 PM
finance.yahoo.com logoUnited States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease
finance.yahoo.com - January 18 at 7:10 PM
marketbeat.com logoMesoblast (NASDAQ:MESO) Upgraded to "Sell" at StockNews.com
marketbeat.com - January 11 at 10:17 PM
marketbeat.com logo
marketbeat.com - January 10 at 6:04 AM
benzinga.com logoMesoblast Stock (NASDAQ:MESO), Short Interest Report
benzinga.com - January 6 at 6:41 PM
benzinga.com logoMesoblast Stock (NASDAQ:MESO) Dividends: History, Yield and Dates
benzinga.com - January 6 at 6:41 PM
finance.yahoo.com logoMesoblast Limited (MESO) Loses -5.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
finance.yahoo.com - January 5 at 5:03 PM
marketbeat.com logo
marketbeat.com - January 5 at 6:04 AM
finance.yahoo.com logoMesoblast Limited (LWB.F)
finance.yahoo.com - December 25 at 5:37 PM
finance.yahoo.com logoMESO Jan 2025 1.500 call
finance.yahoo.com - December 16 at 5:57 PM
fool.com.au logoWhy Fortescue, Mesoblast, Temple & Webster, and Virgin Money shares are rising
fool.com.au - December 12 at 1:06 AM
fool.com.au logoWhy Mesoblast, Navigator Global, Polynovo, and Skycity shares are falling today
fool.com.au - December 8 at 1:14 AM
fool.com.au logoWhy Boss Energy, Core Lithium, Mesoblast, and QBE shares are falling
fool.com.au - December 6 at 11:09 PM
fool.com.au logoWhy Capricorn Metals, Core Lithium, Life360, and Mesoblast shares are dropping today
fool.com.au - December 4 at 11:14 PM
fool.com.au logoWhy is the Mesoblast share price in a trading halt?
fool.com.au - November 30 at 8:58 PM
afr.com logoMesoblast raising $98m; Bells on ticket
afr.com - November 30 at 8:58 PM
marketbeat.com logo
marketbeat.com - November 30 at 5:58 PM
msn.com logoMesoblast Ltd - ADR (MESO) Price Target Increased by 5.79% to 1.56
msn.com - November 27 at 10:42 PM
markets.businessinsider.com logoMesoblast Seeks ODD For Rexlemestrocel-L In Treating Severe Congenital Heart Disease
markets.businessinsider.com - November 27 at 12:49 AM
finance.yahoo.com logoMesoblast Files for Orphan Drug and Pediatric Rare Disease Designations for Rexlemestrocel-L as Treatment for Severe Congenital Heart Disease
finance.yahoo.com - November 26 at 7:48 PM
morningstar.com logoMesoblast Ltd ADR LWBA
morningstar.com - November 25 at 5:42 PM
finance.yahoo.com logoMost Shareholders Will Probably Find That The Compensation For Mesoblast Limited's (ASX:MSB) CEO Is Reasonable
finance.yahoo.com - November 21 at 12:41 AM
markets.businessinsider.com logoBuy Rating for Arcellx Inc.: Promising Phase I Data and Strategic Partnership with Kite Reinforces Long-Term Potential
markets.businessinsider.com - November 1 at 7:07 PM
msn.com logoHolding The Fort: Mesoblast's Path Towards Overcoming FDA Rejection
msn.com - November 1 at 7:07 PM
msn.com logoMesoblast reports Q1 results
msn.com - November 1 at 7:07 PM
finance.yahoo.com logoAppendix 4C Quarterly Activity Report for Quarter Ended September 30, 2023
finance.yahoo.com - October 30 at 11:40 PM
finance.yahoo.com logoMesoblast Ltd (LWBA.MU)
finance.yahoo.com - October 24 at 12:47 AM
finance.yahoo.com logoJane Bell AM Appointed Chair of Mesoblast Audit and Risk Committee
finance.yahoo.com - September 26 at 6:54 AM
Get Mesoblast News Delivered to You Automatically

Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter.



MESO Media Mentions By Week

MESO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MESO
News Sentiment

0.49

0.65

Average
Medical
News Sentiment

MESO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MESO Articles
This Week

7

1

MESO Articles
Average Week

Get Mesoblast News Delivered to You Automatically

Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:MESO) was last updated on 3/4/2024 by MarketBeat.com Staff